686 Results for "

antiproliferative+activity

" in MedChemExpress (MCE) Product Catalog:
Products (686)

686 Results for "antiproliferative+activity" in MCE Product Catalog:

25
25 Publications Verification
Cat. No.: HY-14909
CAS No.: 218600-44-3
Purity:  99.50%
Synonyms: CDDO; RTA 401
Bardoxolone (CDDO; RTA 401) is a Nrf2 activator. Bardoxolone shows anti-SARS-CoV-2 3CLpro with IC50 of 27.99 μM. Bardoxolone activates the Nrf2 pathway and inhibits the NF-κB pathway. Bardoxolone can induce cells differentiation, apoptosis and shows antiproliferative activity against cancer cells. Bardoxolone can increase ROS and decrease intracellular GSH levels. Bardoxolone inhibits Z-VAD-FMK (HY-16658B)-induced necroptosis. Bardoxolone can be used for the research of cancer, inflammation and infection, such as SARS-CoV infection and glioblastoma .
loading...
    loading...
24
24 Cited Publications
Cat. No.: HY-13032B
CAS No.: 1895049-20-3
Purity:  97.04%
Synonyms: GSK 525762C; I-BET 762 besylate
Research Areas:  

Cancer

Molibresib besylate (GSK 525762C; I-BET 762 besylate) is an orally active pan-BET inhibitor that targets and binds to BRD2, BRD3, BRD4 and BRDT. By competitively occupying acetylated lysine binding sites, Molibresib besylate disrupts the interaction between BET proteins and chromatin, thereby effectively inhibiting MYC expression and target gene transcription. Molibresib besylate exhibits broad antiproliferative activity, which not only inhibits cancer cell growth and induces growth arrest, but also downregulates mitosis-related genes and upregulates the level of p-ERK1/2. When combined with MEK inhibitors, Molibresib besylate shows a significant synergistic effect, reduces tumor burden in mouse models of leukemia, modulates the immune microenvironment and prolongs survival. Molibresib besylate is widely applicable to research related to acute myeloid leukemia, multiple myeloma, triple-negative breast cancer, small-cell lung cancer and various advanced refractory solid tumors .
loading...
    loading...
21
21 Cited Publications
Cat. No.: HY-Y0479
CAS No.: 79-33-4
Synonyms: (S)-2-Hydroxypropanoic acid
L-Lactic acid is a buildiing block which can be used as a precursor for the production of the bioplastic polymer poly-lactic acid. L-Lactic acid has antiproliferative activity .
loading...
    loading...
21
21 Cited Publications
Cat. No.: HY-W040233
CAS No.: 867-56-1
Synonyms: (S)-2-Hydroxypropanoic acid sodium
L-lactate Sodium (Sodium (S)-2-hydroxypropanoate) is a buildiing block which can be used as a precursor for the production of the bioplastic polymer poly-lactic acid. L-Lactic acid Sodium has antiproliferative activity .
loading...
    loading...
20
20 Cited Publications
Cat. No.: HY-100004
CAS No.: 1644060-37-6
Purity:  99.14%
Research Areas:  

Cancer

Fumarate hydratase-IN-1 (compound 2) is a cell-permeable fumarate hydratase inhibitor. Fumarate hydratase-IN-1 has antiproliferative activity against several cancer cell lines with a mean IC50 of 2.2 μM .
loading...
    loading...
15
15 Cited Publications
Cat. No.: HY-111109
CAS No.: 1628830-21-6
Purity:  99.59%
Research Areas:  

Cancer

EZM 2302 is a potent and orally active CARM1 inhibitor with an IC50 value of 6 nM. EZM 2302 shows antiproliferative activity and anti-tumor activity. EZM 2302 inhibits PABP1 and SMB expression .
loading...
    loading...
15
15 Cited Publications
Cat. No.: HY-D0884
CAS No.: 27848-80-2
Synonyms: (S)-2-Hydroxypropanoic acid lithium
L-Lactic acid lithium ((S)-2-Hydroxypropanoic acid lithium) is a buildiing block which can be used as a precursor for the production of the bioplastic polymer poly-lactic acid. L-Lactic acid lithium has antiproliferative activity .
loading...
    loading...
14
14 Cited Publications
Cat. No.: HY-14808
CAS No.: 496868-77-0
Purity:  99.18%
Synonyms: ST1926
Target:  

Apoptosis

Research Areas:  

Cancer

Adarotene is an effective apoptosis inducer, which surprisingly produces DNA damage and exhibites a potent antiproliferative activity on a large panel of human tumor cells.
loading...
    loading...
9
9 Cited Publications
Cat. No.: HY-107856
CAS No.: 316-46-1
Purity:  99.92%
Research Areas:  

Cancer

5-Fluorouridine, a metabolite of5-Fluorouracil (HY-90006), is a potent ribozyme self-cleavage inhibitor. 5-Fluorouridine incorporates into both total and poly A RNA and has antiproliferative activity. 5-Fluorouridine induces apoptosis .
loading...
    loading...
7
7 Cited Publications
Cat. No.: HY-N6735
CAS No.: 183506-66-3
Synonyms: OSI 2040
Apicidin (OSI 2040) is a fungal metabolite, acts as an orally active histone deacetylase 7/8 (HDAC7/8) inhibitor, with antiparasitic activity and a broad spectrum antiproliferative activity. Apicidin can be used for cancer research .
loading...
    loading...
7
7 Cited Publications
Cat. No.: HY-124653
CAS No.: 2133499-85-9
Purity:  99.70%
Synonyms: J2
Target:  

HSP

Research Areas:  

Cancer

HSP27 inhibitor J2 (J2) is a HSP27 inhibitor, which significantly induces abnormal HSP27 dimer formation and inhibits a production of HSP27 giant polymers, thereby having an effect of inhibiting a chaperone function of the HSP27 and reducing a cell protection function thereof. HSP27 inhibitor J2 (J2) remarkably enhances the antiproliferative activity of 17-AAG and sensitizes cisplatin-induced lung cancer cell growth inhibition .
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-N1497
CAS No.: 481-42-5
Synonyms: 2-Methyljuglone
Plumbagin (2-Methyljuglone) is a naphthoquinone isolated from Plumbago zeylanica, exhibits anticancer and antiproliferative activities .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-18336
CAS No.: 328541-79-3
Target:  

CFTR

Research Areas:  

Cardiovascular Disease

GlyH-101 is a potent CFTR inhibitor. GlyH-101 also is a potent and reversible inhibitor of the VSORC conductance. GlyH-101 shows antiproliferative activity. GlyH-101 inhibits CFTR-like current and VSORC current .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-101667
CAS No.: 1879887-96-3
Purity:  99.35%
Target:  

DNA-PK

Research Areas:  

Cancer

LTURM34 is a specific DNA-PK inhibitor (IC50=34 nM). LTURM34 exhibits 170-fold selectivity for DNA-PK over PI3K. LTURM34 shows potent antiproliferative activity in a wide range of tumor cell lines .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-120599
CAS No.: 1332881-26-1
Purity:  99.00%
Synonyms: VERU-111; ABI-231
Research Areas:  

Cancer

VERU-111 (ABI-231) is a potent and orally active α and β tubulin inhibitor, which displays strong antiproliferative activity, with an average IC50 of 5.2 nM against panels of melanoma and prostate cancer cell lines. VERU-111 (ABI-231) suppresses tumor growth and metastatic phenotypes of cervical cancer cells via targeting HPV E6 and E7, and has potential for the treatment of prostate cancer .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-12868
CAS No.: 1225037-39-7
Purity:  98.62%
Synonyms: PQR309
Target:  

PI3K mTOR Apoptosis

Research Areas:  

Cancer

Bimiralisib (PQR309) is an orally active, blood-brain barrier-penetrant PI3K/mTOR inhibitor with in vitro antiproliferative activity and in vivo antitumor activity. Bimiralisib induces G1 cell cycle arrest, apoptosis and cell death in cancer cells, while inhibiting cancer cell proliferation, migration, invasion, colony formation and spheroid generation. Bimiralisib upregulates the expression of E2F4. The combination of Bimiralisib with venetoclax enhances therapeutic efficacy in acute myeloid leukemia models. Bimiralisib can be used in cancer-related research .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-118384
CAS No.: 18417-89-5
Purity:  97.68%
Synonyms: NSC 65346; BA-90912
Sangivamycin (NSC 65346), a nucleoside analog, is a potent inhibitor of protein kinase C (PKC) with an Ki of 10 μM. Sangivamycin has potent antiproliferative activity against a variety of human cancers .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-122844A
Synonyms: BI-853520 hydrochloride; IN-10018 hydrochloride
Target:  

FAK

Research Areas:  

Cancer

Ifebemtinib (BI-853520) hydrochloride is an orally active and potent focal adhesion kinase (FAK) inhibitor (IC50 = 1 nM for recombinant FAK). Ifebemtinib hydrochloride exhibits antiproliferative activity against cancer cells .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-12025
CAS No.: 881202-45-5
Purity:  99.56%
Synonyms: JNJ-26854165
Research Areas:  

Cancer

Serdemetan (JNJ-26854165) is a potent anticancer agent with radiosensitizing activity. Serdemetan exhibits antiproliferative activity in various p53 wild-type tumor cells. Serdemetan also antagonizes the Mdm2-HIF1α axis leading to decreased levels of glycolytic enzymes .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-122639
CAS No.: 591239-68-8
Purity:  99.33%
Target:  

NEKs

Research Areas:  

Cancer

ZINC05007751 is a potent NIMA-related kinase NEK6 inhibitor with an IC50 of 3.4 μM. ZINC05007751 shows antiproliferative activity against a panel of human cancer cell lines, and displays a synergistic effect with Cisplatin and Paclitaxel in a BRCA2 mutated ovarian cancer cell line. ZINC05007751 is very selective against NEK1 and NEK6 with no significant activity was observed against NEK2, NEK7, and NEK9 .
loading...
    loading...